ALFA FinderBSE filing, NSE: DABUR. Summary written from the filing by ALFA Finder's alert engine.
Dabur India Ltd: key numbers
- Share price
- ₹380.50
- Market cap
- ₹67,503 Cr
- Revenue (annual)
- ₹13,193 Cr
- Net profit (annual)
- ₹1,895 Cr
- P/E (TTM)
- 33.3×Sector 40.7×
- Promoter holding
- 66.25%+0.01% QoQ
- FII holding
- 9.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dabur India Ltd
All →Dabur India Merger & Restructuring
Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.
Dabur India Legal & Regulatory
Dabur received a SEBI administrative warning for delayed disclosure of a USFDA warning letter. No monetary penalty or financial impact is reported.
Dabur India Earnings Call Transcript: Key Takeaways
Consolidated revenue grew 11.6%, the second straight double-digit quarter. India standalone grew 8.9%, and India FMCG grew 10.7% on 5.5% volume and 5.2% price. Management reiterated double-digit full-year guidance and called its M&A progress red.
Dabur India Employee Stock Options
Dabur India Ltd has allotted 480 equity shares of Re. 1 each under its Employees Stock Option Scheme 2000. This increases the total paid-up equity capital to Rs. 177.40 Crore.
Dabur India Dividend
Dabur India declared an interim dividend of Rs 3.5 per share for FY 2026-27. Record date is 10 November 2026.
Dabur India Management Change
Dabur India announced changes after its 4 November 2026 board meeting: Global CEO Mohit Malhotra resigned and Herjit Singh Bhalla was appointed Additional and Whole-time Director. Other director, KMP and compliance officer changes were also approved.
Other other announcement announcements
All →Imagicaaworld Entertainment Other Announcement
Imagicaaworld filed the Monitoring Agency Report on preferential issue proceeds for the quarter ended 30 September 2026. The agency reported no deviation from the stated objects.
Star Delta Transformers Other Announcement
Star Delta Transformers filed its half-year related party transactions disclosure with BSE under Regulation 23(9). It is routine periodic compliance with no new capital or deal.
Park Medi World Other Announcement
Park Medi World filed Crisil's monitoring agency report on IPO proceeds for quarter ended September 30, 2026. Utilisation deviated from prospectus objects, reallocated under shareholder approval.
AKG Exim Other Announcement
AKG Exim filed its consolidated related party transactions disclosure for the half year ended September 30, 2026. It lists routine dealings with directors, KMP and related entities.
Prodocs Solutions Other Announcement
Prodocs Solutions submitted its IPO proceeds monitoring report for the quarter ended September 30, 2026. No deviation from issue objects was reported, so it is routine compliance.
CPS Shapers Other Announcement
CPS Shapers filed auditor certificates on preferential issue proceeds utilised until 30 September 2026. The filing reports utilisation only, with no new capital raised.